Agios Pharmaceuticals (AGIO) Technical Analysis

As of 2026-07-22, AGIO last traded at 36.05 USD (-3.51% on the day) and is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Nearest levels: 32.47 USD support below, 36.35 USD resistance above. 14-day RSI is 47.1 (neutral).

Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is AGIO in an uptrend or downtrend?

Agios Pharmaceuticals is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA.

Last close36.05 USD (-3.51%)
20-day average39.025 USD
50-day average33.285 USD
200-day average31.853 USD

Key support and resistance levels for AGIO

Derived from swing pivots over the last 200 sessions:

LevelTypeStrengthTouches
36.35 USDResistanceMinor1
43.21 USDResistanceMinor1
43.69 USDResistanceMinor1
LevelTypeStrengthTouches
32.47 USDSupportMinor1
27.425 USDSupportModerate2
26.84 USDSupportMinor1

AGIO 52-week range, momentum and volatility

52-week high46 USD (21.6% below)
52-week low22.24 USD (62.1% above)
14-day RSI47.1 (Neutral)
14-day ATR2.03 USD (5.63% of price, High volatility)

Related research pages

Frequently asked questions

Is Agios Pharmaceuticals (AGIO) in an uptrend or downtrend?

As of 2026-07-22, AGIO is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Last close 36.05 USD vs 50-day average 33.285 USD and 200-day average 31.853 USD.

What are the key support and resistance levels for AGIO?

Nearest support is around 32.47 USD (minor, 1 touch). Nearest resistance is around 36.35 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.

What is AGIO's 52-week high and low?

Over the last 52 weeks, AGIO traded between 22.24 USD and 46 USD. It is currently 21.6% below its 52-week high.

Is AGIO overbought or oversold?

The 14-day RSI is 47.1 — in a neutral 30–70 range. Momentum reads as neutral.

How volatile is AGIO?

Its 14-day Average True Range is 2.03 (5.63% of price) — high volatility relative to price.